Terns Pharmaceuticals, Inc. (TERN)
NASDAQ: TERN · Real-Time Price · USD
2.760
-0.160 (-5.48%)
At close: Mar 31, 2025, 4:00 PM
2.770
+0.010 (0.37%)
After-hours: Mar 31, 2025, 7:45 PM EDT
Terns Pharmaceuticals Employees
Terns Pharmaceuticals had 59 employees as of December 31, 2024. The number of employees decreased by 7 or -10.61% compared to the previous year.
Employees
59
Change (1Y)
-7
Growth (1Y)
-10.61%
Revenue / Employee
n/a
Profits / Employee
-$1,505,983
Market Cap
240.94M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 59 | -7 | -10.61% |
Dec 31, 2023 | 66 | 20 | 43.48% |
Dec 31, 2022 | 46 | 5 | 12.20% |
Dec 31, 2021 | 41 | 11 | 36.67% |
Dec 31, 2020 | 30 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
TERN News
- 11 days ago - Terns Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Updates - GlobeNewsWire
- 4 weeks ago - Terns Pharmaceuticals Reports Inducement Grant to New Chief Financial Officer Under Nasdaq Listing Rule 5635(C)(4) - GlobeNewsWire
- 4 weeks ago - Terns Pharmaceuticals Provides Program Updates and Announces Participation at TD Cowen 45th Annual Healthcare Conference - GlobeNewsWire
- 5 weeks ago - Terns Pharmaceuticals Appoints Andrew Gengos as Chief Financial Officer - GlobeNewsWire
- 5 weeks ago - Terns Pharmaceuticals Appoints Robert Azelby to Board of Directors - GlobeNewsWire
- 7 weeks ago - Terns Pharmaceuticals to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference - GlobeNewsWire
- 2 months ago - Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4) - GlobeNewsWire
- 2 months ago - Terns Pharmaceuticals to Present at 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire